Enteral Feeding Formula Market Report 2025

The enteral feeding formula market size has grown strongly in recent years. It will grow from $6.53 billion in 2024 to $7.16 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to rising geriatric population, increased prevalence of chronic diseases, technological advancements in enteral feeding formula, growing awareness of clinical nutrition, expansion of home healthcare services.

The enteral feeding formula market size is expected to see rapid growth in the next few years. It will grow to $10.67 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to growing incidence of malnutrition, expansion of the elderly population, advances in enteral nutrition research, increasing adoption of home enteral nutrition, rise in the number of hospitals and long-term care facilities. Major trends in the forecast period include development of disease-specific enteral feeding formulas, demand for plant-based and organic formulas, focus on immunonutrition in enteral feeding, customized enteral nutrition solutions, adoption of blenderized tube feeding formulas.

The growing geriatric population will propel the growth of the enteral feeding formula market. Globally, the number of people aged 65 years or above was increasing in recent years. The geriatric population is most vulnerable to chronic disorders and often requires feeding through the enteral route. Thus, the increasing number of old age people increases the demand for enteral foods. For instance, in October 2022, according to the World Health Organization, a Switzerland-based international public health organization, the global population of individuals aged 60 years is projected to increase to 1. 4 billion by 2022 compared to 1 billion in 2020. Moreover, 1 out of 6 people in the world will be aged more than 60 years or older by 2030. Therefore, the growing geriatric population will drive the growth of the enteral feeding formula market forward.

Increasing demand for home care services is expected to propel the market for enteral feeding formulas going forward. Home care services refer to a wide range of supportive services for individuals who need assistance with daily activities but wish to remain in the comfort of their own homes. Enteral feeding is increasingly used in home-based care for patients who require long-term nutritional support. For instance, in December 2022, according to a report published by integrated Home Care Services, Inc. (IHCS), a US-based home care management company, approximately 80% of survey participants anticipated a lasting rise in the utilization of home care services. Thus, increasing demand for home care services will drive the growth of the enteral feeding formula market.

Product innovations are a key trend gaining popularity in the enteral feeding formula market. Major companies in the market are constantly innovating and launching newer enteral formulas. The launch of new products provides customers with more options and increases demand for enteral feeding formulas, which drives the enteral feeding formula market. For instance, in September 2023, Cardinal Health, Inc., a US-based health care services company, launched the Kangaroo OMNI Enteral Feeding Pump in the United States. This innovative pump is designed to offer enteral feeding patients a range of options tailored to their specific needs throughout their enteral feeding journey. Kangaroo OMNI is the first and only attitude-independent enteral feeding system in the U. S. that can deliver thick, homogenized, and blended formulas. With its compact and portable design, it provides versatility for feeding, flushing, and hydration, along with the capability to transmit a 30-day feeding history. Kangaroo OMNI is a comprehensive solution designed to address the enteral feeding requirements of patients and caregivers, whether in a hospital or home setting.

Major companies in the enteral feeding formulas market are developing technologically advanced products, such as enteral feeding pumps, to enhance their product offerings. An enteral feeding pump is a medical device designed to deliver liquid nutrition directly into a patient's stomach or intestines through a feeding tube, ensuring precise and controlled nutrient administration for individuals unable to eat by mouth. For instance, in September 2023, Cardinal Health, a US-based healthcare company, launched the Kangaroo OMNI enteral feeding pump. This pump is designed to provide enteral feeding patients with enhanced options tailored to their individual needs, featuring portability and versatility for delivering thick formulas and hydration across various care settings. It offers improved water resistance, allowing it to be cleaned under running water, and includes compatible accessories such as a pole clamp and table stand. Additionally, the pump can display screen content in 19 different languages.

In May 2024, Danone, a France-based food and beverage company, acquired Functional Formularies for an undisclosed amount. This acquisition will enable Danone to enhance its offerings for individuals with special medical needs, particularly in the enteral tube-feeding segment. With the integration of Functional Formularies' highly differentiated product portfolio, which complements Danone's existing Real Food Blends range, the company is now better equipped to meet the nutritional needs of tube-fed patients and their families. Functional Formularies is a US-based provider of enteral feeding formulas.

Major companies operating in the enteral feeding formula market include Abbott Laboratories, Nestlé S. A., Danone S. A., Fresenius Kabi AG, B. Braun Melsungen AG, Meiji Holdings Co. Ltd., Real Food Blends, Ajinomoto Cambrooke Inc., Otsuka Pharmaceutical Co. Ltd., Medtrition Inc., Nutri-Force Nutrition, Global Health Product Inc., VICTUS, Primus Pharmaceuticals Inc., Kate Farms, Baxter International Inc., Perrigo Nutritionals LLC, Reckitt Benckiser Group plc, Bio-Serv Inc., Nutrabalace Ltd., ProSynbiotics, Med-Diet Laboratories Inc., Precision Foods-kent corporation, SimplyThick LLC, Coram LLC, Vitaflow LLC.

The enteral feeding formulas are food formulations containing specific nutrients as per the need of the consumer. Patients who are in intensive care or are unable to swallow the food, need certain nutrients. The enteral feeding formulations can fulfil the nutrients and nutritional requirements. They are used for directly delivering the food or nutrients to the patient’s stomach or small intestine.

The main products of enteral feeding formulas are standard formulas and disease-specific formulas. Standard feeding formulas are formulas intended for people with normal digestion. Standard formulas consist of all the nutrients that are required to maintain health. The stages are adults and pediatrics. The applications of enteral feeding formulas are oncology, gastroenterology, neurology, diabetes, critical care, and other applications. Hospitals and long-term care facilities are the end users of enteral feeding formulas.

The enteral feeding formulas market research report is one of a series of new reports that provides enteral feeding formulas market statistics, including enteral feeding formulas industry global market size, regional shares, competitors with a enteral feeding formulas market share, detailed enteral feeding formulas market segments, market trends and opportunities, and any further data you may need to thrive in the enteral feeding formulas industry. This enteral feeding formulas market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

North America was the largest region in the enteral feeding formula market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enteral feeding formula market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the enteral feeding formula market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The enteral feeding formulas consists of sales of diabetic formula, renal formula, hepatic formula, pulmonary formula and peptide-based formula. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.